MDXG
MiMedx Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+3.16%Forward multiples
Based on analyst estimates
- P/E forward
- 107.53x
- P/E 2026E
- —
- P/E 2027E
- 60.33x
- P/E 2028E
- 20.88x
- P/S forward
- 2.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- 114.25x
- PEG TTM
- 18.10x
- Price / book
- 3.08x
- Price / sales
- 1.88x
- Price / cash flow
- 14.43x
Enterprise value
- Enterprise value
- $531.8M
- EV / sales
- 1.50x
- EV / EBITDA
- 22.44x
- EV / EBIT
- 60.77x
- Market cap
- $666.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026